Quantcast

Latest Pluripotency Stories

2010-04-25 15:19:47

Better understanding of mechanisms involved should improve reprogramming of embryonic-like cells Scientists may be one step closer to being able to generate any type of cells and tissues from a patient's own cells. In a study that will appear in the journal Nature and is receiving early online release, investigators from the Massachusetts General Hospital Center for Regenerative Medicine (MGH-CRM) and the Harvard Stem Cell Institute (HSCI), describe finding that an important cluster of genes...

4ad091ff8556ebe443d1703cee2ae75f1
2010-04-23 11:15:00

Officials at the Vatican announced on Friday they will begin financing research into the medical use of adult stem cells. The Vatican has already committed $2.7 million for the research, and according to the Associated Press (AP), "The project is at a very preliminary phase and it will be years before any clinical treatment might be available." The Vatican proposal has the support of the Catholic Church, Cardinal Renato Martino told the AP, because it does not involve the use of embryonic...

2010-04-21 06:00:00

MADISON, Wis., April 21 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List. Utilizing research emerging from Dr. Thomson's laboratory,...

2010-04-16 14:13:18

Finding is expected to steer future work on therapies down the most efficient and promising paths Researchers in China are reporting that they have found a way to determine which somatic cells -- or differentiated body cells -- that have been reprogrammed into a primordial, embryonic-like state are the most viable for therapeutic applications. In a paper published online last week by the Journal of Biological Chemistry, two collaborating teams from institutes at the Chinese Academy of...

2010-04-15 14:29:34

A new technique for reprogramming human adult cells could greatly improve the safety and efficiency of producing patient-specific stem cells for use in a range of therapeutic applications to repair or replace damaged or diseased tissues. A description of this innovative strategy is published in the peer-reviewed journal Cellular Reprogramming, published by Mary Ann Liebert, Inc. The paper is available free online. Stem cells offer great promise for use in cellular therapy to regenerate...

2010-04-14 13:02:01

At Rutgers' Stem Cell Research Center scientists are exploring the mysteries of human embryonic stem cells and their potential use in treating diseases, repairing damaged organs, and drug development. Center staff also offer a course in proper lab techniques in working with stem cells. The center was established with a grant to Professors Martin Grumet and Wise Young  from the State of New Jersey through its Commission on Science and Technology. The center focuses on human embryonic stem...

2010-04-13 08:49:50

The groundbreaking new findings will speed research on potential therapies Scientists at The Scripps Research Institute have solved the decade-old mystery of why human embryonic stem cells are so difficult to culture in the laboratory, providing scientists with useful new techniques and moving the field closer to the day when stem cells can be used for therapeutic purposes. The research is being published in the journal Proceedings of the National Academy of Sciences (PNAS) during the week of...

2010-03-15 12:33:39

In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to...

2010-03-02 06:00:00

MADISON, Wis., March 2 /PRNewswire/ -- Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11. The workshop, entitled "Toxicology in the 21st Century: Stem Cells in Drug Discovery and Development," will present the current understanding of pluripotent stem cells and their utility in providing cellular models, how they are being employed to...

2010-02-26 07:00:00

SAN DIEGO, Feb. 26 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related